Advancis Pharmaceutical Corporation

Quick facts

Phase 3 pipeline

• Amoxicillin Pulsatile Release Multiparticluate Sprinkle · Infectious Disease
  Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, delivered via a pulsatile release multiparticulate sprinkle formulation for modified pharmacokinetics.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Advancis Pharmaceutical Corporation portfolio CI brief
• Advancis Pharmaceutical Corporation pipeline updates RSS